Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Myofibroblast activation is a complex cellular process involving the transformation of various precursor cells into contractile myofibroblasts. These cells are characterized by their ability to produce extracellular matrix (ECM) components and generate contractile forces. Key stimulatory factors include growth factors (TGF-β1, PDGF, CTGF), ECM components (ED-A FN, ECM stiffness), and mechanical stimuli (strained ECM, increased tissue stiffness). Signaling pathways involved include TGF-β, calcium, cAMP, and mitochondrial signaling. The process occurs in stages, from proto-myofibroblast to fully activated myofibroblast, marked by α-SMA expression. Therapeutic approaches aim to modulate these signaling pathways to treat fibrotic diseases and wound healing disorders.
Varies depending on the specific target involved in myofibroblast activation. For example, forskolin stimulates adenylyl cyclase, increasing cAMP levels and inhibiting myofibroblast transformation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myofibroblast Activation.